$96.01
1.19% yesterday
NYSE, Sep 27, 10:00 pm CET
ISIN
US29261A1007
Symbol
EHC

Encompass Health Corporation Stock price

$96.01
+4.72 5.17% 1M
+18.30 23.55% 6M
+29.29 43.90% YTD
+28.90 43.06% 1Y
+34.40 55.83% 3Y
+46.56 94.17% 5Y
+66.82 228.94% 10Y
NYSE, Closing price Fri, Sep 27 2024
-1.16 1.19%
ISIN
US29261A1007
Symbol
EHC
Sector

Key metrics

Market capitalization $9.78b
Enterprise Value $13.11b
P/E (TTM) P/E ratio 24.76
EV/FCF (TTM) EV/FCF 63.41
EV/Sales (TTM) EV/Sales 2.59
P/S ratio (TTM) P/S ratio 1.93
P/B ratio (TTM) P/B ratio 5.32
Dividend yield 0.62%
Last dividend (FY23) $0.60
Revenue growth (TTM) Revenue growth 10.86%
Revenue (TTM) Revenue $5.07b
EBIT (operating result TTM) EBIT $792.40m
Free Cash Flow (TTM) Free Cash Flow $206.80m
Cash position $299.40m
EPS (TTM) EPS $3.92
P/E forward 23.49
P/S forward 1.84
EV/Sales forward 2.47
Short interest 1.44%
Show more

Is Encompass Health Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Encompass Health Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Encompass Health Corporation forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a Encompass Health Corporation forecast:

Buy
92%
Hold
8%

Financial data from Encompass Health Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
5,071 5,071
11% 11%
100%
- Direct Costs 4,075 4,075
10% 10%
80%
996 996
14% 14%
20%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
1,073 1,073
13% 13%
21%
- Depreciation and Amortization 281 281
7% 7%
6%
EBIT (Operating Income) EBIT 792 792
15% 15%
16%
Net Profit 398 398
28% 28%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Encompass Health Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Encompass Health Corporation Stock News

Neutral
PRNewsWire
3 days ago
The 39-bed inpatient rehabilitation hospital is Encompass Health's 165th hospital. BIRMINGHAM, Ala.
Neutral
PRNewsWire
about 2 months ago
Increases full-year guidance BIRMINGHAM, Ala. , Aug. 5, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the second quarter ended June 30, 2024.
More Encompass Health Corporation News

Company Profile

Encompass Health Corp. engages in providing post-acute healthcare services. It operates through the following segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac & pulmonary conditions, brain & spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

Head office United States
CEO Mark Tarr
Employees 37,761
Founded 1984
Website www.encompasshealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today